Pharmaceutical metered dose inhaler and methods relating thereto

Details for Australian Patent Application No. 2004264941 (hide)

Owner Glaxo Group Limited

Inventors Sommerville, Mark Lee; Miller, John Francis

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004264941

PCT Pub. Number WO2005/016410

Priority 60/494,450 11.08.03 US

Filing date 11 August 2004

Wipo publication date 24 February 2005

Acceptance publication date 27 November 2008

International Classifications

A61M 39/00 (2006.01) Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

C08C 3/02 (2006.01) Treatment of coagulated rubber

C08F 6/00 (2006.01) Post-polymerisation treatments

C08K 5/09 (2006.01) Use of organic ingredients

C08K 5/13 (2006.01) Use of organic ingredients

C08K 5/00 (2006.01) Use of organic ingredients

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016410 Priority application(s): WO2005/016410

27 November 2008 Application Accepted

  Published as AU-B-2004264941

26 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264944-Orally administered small peptides synergize statin activity

2004264939-Robust pellet